CSL Behring

CSL Behring



Bookmark and Share Print This Page
CSL Behring, a leader in the plasma protein therapeutics industry. researches, develops, manufactures and markets plasma-derived and recombinant therapies worldwide that are used to treat coagulation disorders including hemophilia and von Willebrand disease, primary immune deficiencies, hereditary angioedema and inherited respiratory disease. The company’s products are also used in cardiac surgery, organ transplantation, burn treatment and to prevent hemolytic disease of the newborn.

CSL Behring’s subsidiary, CSL Plasma, operates one of the largest plasma collection networks in the world. CSL Behring is a subsidiary of CSL Limited (ASX:CSL), a biopharmaceutical company headquartered in Melbourne, Australia.